Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Increased serum insulin-like growth factor 1 in early idiopathic Parkinson's disease | Synapse

February 22, 2010

Ver artículo completo

Increased serum insulin-like growth factor 1 in early idiopathic Parkinson's disease

JGJana GodauKlinikum Kassel MHManon HerfurthGerman Center for Neurodegenerative Diseases BKBarbara KattnerUniversity of Tübingen

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Increased IGF-1 might be an interesting serum marker for early PD and potentially for subclinical dopaminergic dysfunction.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Godau et al. (Mon,) studied this question.

synapsesocial.com/papers/69d76335086f9d6299f30ca1 https://doi.org/https://doi.org/10.1136/jnnp.2009.175752

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Comparison of pramipexole and amisulpride on alertness, autonomic and endocrine functions in healthy volunteers2006 · 37 citations
2Neuroendocrine and side effect profile of pramipexole, a new dopamine receptor agonist, in humans1992 · 41 citations
3Growth Hormone Therapy in the Glucocorticosteroid-Dependent Child: Metabolic and Linear Growth Effects2001 · 79 citations
4A Study of Dopaminergic Sensitivity in Parkinson's Disease: Comparison in “De Novo” and Levodopa-Treated Patients1996 · 13 citations
5Effect of hypoglycaemia, TRH and levodopa on plasma growth hormone, prolactin, thyrotropin and cortisol in Parkinson's disease before and during therapy1986 · 20 citations